Evidence map›Paper›PMID 31076457›Full record

ArticleJournal of investigative medicine : the official publication of the American Federation for Clinical Research2019

Daily supplementation with 5 mg of folic acid in Brazilian patients with hereditary spherocytosis.

Clóvis Paniz, Maylla Rodrigues Lucena, Juliano Felix Bertinato, Felipe Rebello Lourenço, Bruna Cipriano A Barros, Guilherme Wataru Gomes, Maria Stella Figueiredo, Rodolfo Delfini Cançado, Vera Lúcia Nascimento Blaia-D Avila, Christine M Pfeiffer and 4 more

Abstract read
In one paragraph

Article in Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Clóvis PanizAnálises Clínicas e Toxicológicas, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0001-6676-2970
Maylla Rodrigues LucenaDisciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, São Paulo, Brazil.
Juliano Felix BertinatoAnálises Clínicas e Toxicológicas, Universidade de São Paulo, São Paulo, Brazil.
Felipe Rebello LourençoFarmácia, Universidade de São Paulo, São Paulo, Brazil.
Bruna Cipriano A BarrosDisciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, São Paulo, Brazil.
Guilherme Wataru GomesAnálises Clínicas e Toxicológicas, Universidade de São Paulo, São Paulo, Brazil.
Maria Stella FigueiredoDisciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, São Paulo, Brazil.
Rodolfo Delfini CançadoSeção de Hematologia e Oncologia, Faculdade de Medicina da Santa Casa de São Paulo, São Paulo, Brazil.
Vera Lúcia Nascimento Blaia-D AvilaDivisão de Hematologia, Pontificia Universidade Católica de São Paulo, Sorocaba, Brazil.
Christine M PfeifferCDC, National Center for Environment Health, Atlanta, Georgia, USA.
Zia FaziliCDC, National Center for Environment Health, Atlanta, Georgia, USA.
Ralph GreenPathology and Laboratory Medicine, UC Davis School of Medicine, Sacramento, California, USA.
Valdemir Melechco CarvalhoGrupo Fleury, São Paulo, Brazil.
Elvira Maria Guerra-ShinoharaAnálises Clínicas e Toxicológicas, Universidade de São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRUniversidade Federal de São Paulo · BRNational Center for Environmental Health · USFaculdade de Ciências Médicas da Santa Casa de São Paulo · BRFleury S.A. (Brazil) · BRPontifícia Universidade Católica de São Paulo · BRUniversity of California, Davis · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Patients with hereditary spherocytosis (HS) have increased rates of erythropoiesis and higher folate requirements. In a case-control study of patients with HS, we evaluated the associations between the use of 5 mg folic acid (FA) daily and serum concentrations of folate, unmetabolized folic acid (UMFA), interleukin (IL)-6, IL-8, IL-10, interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α); and mRNA expression of

Indexed as

Dietary SupplementsAdultBrazilCase-Control StudiesEnergy IntakeFemaleFolic AcidGene Expression RegulationHumansMaleRNA, MessengerSpherocytosis, HereditaryStatistics, NonparametricFolic AcidRNA, Messengercytokinesfolic acid

Identifiers

PMID31076457
PMCPMC7065022
OpenAlexW2944750010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.